Sue Reynolds

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Centers for Disease Control and Prevention(Current)

Kaiser Permanente Center for Health Research

Baylor Scott & White Health

Abt Global (United States)

Kaiser Permanente

Sue Reynolds is an author at Centers for Disease Control and Prevention specializing in infectious diseases, veterinary medicine, and vaccine efficacy.

ORCID

Publications per year

2013–2023

Publications

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

Mark G. Thompson, Edward Stenehjem, Shaun J. Grannis et al. · New England Journal of Medicine · 2021 · 507 citations · Full text

Veterinary Medicine, Emergency Medicine, Infectious Diseases +17

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 476 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Mark G. Thompson, Karthik Natarajan, Stephanie A. Irving et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 431 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015

Jill M. Ferdinands, Alicia M. Fry, Sue Reynolds et al. · Clinical Infectious Diseases · 2016 · 204 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

Nicola P. Klein, Melissa S. Stockwell, Maria Demarco et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 194 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +14

1–5 of 23